A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Purpose: Despite the wide adoption of tumor molecular profiling, there is a dearth of evidence linking molecular biomarkers for treatment selection to prediction of treatment outcomes in patients with metastatic pancreatic cancer. We initiated a pilot study to test the feasibility of designing a lar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pancreat Cancer
Autors principals: Tesfaye, Anteneh A., Wang, Hongkun, Hartley, Marion L., He, Aiwu Ruth, Weiner, Louis, Gabelia, Nina, Kapanadze, Lana, Shezad, Muhammad, Brody, Jonathan R., Marshall, John L., Pishvaian, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc., publishers 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503449/
https://ncbi.nlm.nih.gov/pubmed/31065624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/pancan.2019.0003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars